As of 2025-07-16, the Fair Value of Neuropace Inc (NPCE) is -3.78 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.35 USD, the upside of Neuropace Inc is -140.44%.
With the market price of 9.35 USD and our fair value calculation, Neuropace Inc (NPCE) is not a good investment. Investing in NPCE stocks now will result in a potential loss of 140.44%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -24.28 | -36.08 | -47.08 | -32.96 | -27.14 | -33.51 |
| YoY growth | 18.99% | -48.60% | -30.49% | 30.00% | 17.64% | -2.49% |
| Market Cap (mil) | 306.68 |
| P/E | |
| Forward P/E |
| EPS | -0.76 |
| Avg earnings growth rate | -2.49% |
| TTM earnings | -24.80 |